2Suppliers
2Customers
0Debt Items
20Related Chains

Source-Backed Evidence Depth

Adaptimmune Therapeutics PLC (ADAPY) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

4Total relationships
0Distinct source URLs
0High confidence
0.720Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Adaptimmune Therapeutics PLC Suppliers

TickerNameConfidenceEvidence
CRBU Caribou Biosciences, Inc. 72% Reciprocal relationship from CRBU graph: Reciprocal relationship from ADAPY graph: Reciprocal relationship from CRBU graph: Reciprocal relationship from ADAPY graph: Reciprocal relationship from CRBU…
INAB IN8bio, Inc. 72% Reciprocal relationship from INAB graph: nt to the UABRF license agreement, see the section titled “Business—Intellectual Property.” Sales and Marketing Given our stage of development, we have not ye…

Adaptimmune Therapeutics PLC Customers

TickerNameConfidenceEvidence
CRBU Caribou Biosciences, Inc. 72% Reciprocal relationship from CRBU graph: untries where our product candidates may be sold at lower prices than in the United States. Third-party payors, whether domestic or foreign, governmental or c…
INAB IN8bio, Inc. 72% Reciprocal relationship from INAB graph: Reciprocal relationship from ADAPY graph: Reciprocal relationship from INAB graph: nt to the UABRF license agreement, see the section titled “Business—Intelle…

Adaptimmune Therapeutics PLC Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Adaptimmune Therapeutics PLC.

Adaptimmune Therapeutics PLC Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Adaptimmune Therapeutics PLC.

Adaptimmune Therapeutics PLC Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Adaptimmune Therapeutics PLC.

Adaptimmune Therapeutics PLC Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
INAB IN8bio, Inc. 100.00 1 ['customer', 'supplier']
CRBU Caribou Biosciences, Inc. 100.00 1 ['customer', 'supplier']
EDIT Editas Medicine, Inc. 50.00 2
REGN Regeneron Pharmaceuticals, Inc. 50.00 2
ALLO Allogene Therapeutics, Inc. 50.00 2
ATRA Atara Biotherapeutics, Inc. 50.00 2
CGEM Cullinan Therapeutics, Inc. 50.00 2
ARTV Artiva Biotherapeutics, Inc. 50.00 2
HCWB HCW Biologics Inc. 50.00 2
IPSC Century Therapeutics, Inc. 50.00 2
JANX Janux Therapeutics, Inc. 50.00 2
MGX Metagenomi Therapeutics, Inc. 50.00 2
IOVA Iovance Biotherapeutics, Inc. 50.00 2
LEGN Legend Biotech Corporation 50.00 2
NTLA Intellia Therapeutics, Inc. 50.00 2
PRME Prime Medicine, Inc. 50.00 2
STTK Shattuck Labs, Inc. 50.00 2
CMOS CMOS 50.00 2
UABRF UABRF 50.00 2
CELG-RI BRISTOL MYERS SQUIBB CO 50.00 2
🔐
ADAPY
Unlock ADAPY Supply Chain Data
Verified relationships include:
CRBUCaribou Biosciences, Inc.Supplier72%
INABIN8bio, Inc.Supplier72%
CRBUCaribou Biosciences, Inc.Customer72%
INABIN8bio, Inc.Customer72%
Subscribe — View plans →